Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

Fig. 1

The IBD pathogenesis. The interactions between environmental factors, genetic susceptibility, and microbial flora may perturb intestinal hemostasis and thus induce the transduction of dysregulated immune responses and underlie resultant tissue damage. Inflammatory bowel diseases (IBD), innate lymphoid cells (ILC), T helper cell (Th), interleukin (IL), transforming growth factor-beta (TGF-β), regulatory B cells (Bregs), regulatory T cells (Tregs), regulatory dendritic cells (rDCs), natural killer T (NKT) cells, tumor necrosis factor α (TNFα)

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us